Free Trial

Mirion Technologies (MIR) Competitors

Mirion Technologies logo
$13.64 -1.39 (-9.22%)
Closing price 04/3/2025 03:58 PM Eastern
Extended Trading
$13.64 0.00 (-0.03%)
As of 04:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MIR vs. RVTY, AVTR, BIO.B, NVMI, VNT, ST, CAMT, TXG, TRNS, and CTKB

Should you be buying Mirion Technologies stock or one of its competitors? The main competitors of Mirion Technologies include Revvity (RVTY), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Vontier (VNT), Sensata Technologies (ST), Camtek (CAMT), 10x Genomics (TXG), Transcat (TRNS), and Cytek Biosciences (CTKB). These companies are all part of the "measuring and control equipment" industry.

Mirion Technologies vs.

Mirion Technologies (NYSE:MIR) and Revvity (NYSE:RVTY) are both business services companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership, community ranking and earnings.

Mirion Technologies has a beta of 0.74, indicating that its share price is 26% less volatile than the S&P 500. Comparatively, Revvity has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500.

Revvity has a net margin of 9.81% compared to Mirion Technologies' net margin of -4.21%. Revvity's return on equity of 7.68% beat Mirion Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Mirion Technologies-4.21% 4.78% 2.81%
Revvity 9.81%7.68%4.62%

Revvity has higher revenue and earnings than Mirion Technologies. Mirion Technologies is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mirion Technologies$860.80M3.68-$36.10M-$0.19-71.81
Revvity$2.76B4.39$270.39M$2.2145.59

78.5% of Mirion Technologies shares are owned by institutional investors. Comparatively, 86.7% of Revvity shares are owned by institutional investors. 2.2% of Mirion Technologies shares are owned by company insiders. Comparatively, 0.7% of Revvity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Mirion Technologies currently has a consensus target price of $19.25, suggesting a potential upside of 41.09%. Revvity has a consensus target price of $136.25, suggesting a potential upside of 35.22%. Given Mirion Technologies' stronger consensus rating and higher possible upside, research analysts plainly believe Mirion Technologies is more favorable than Revvity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mirion Technologies
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.40
Revvity
0 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.77

Revvity received 13 more outperform votes than Mirion Technologies when rated by MarketBeat users. However, 84.21% of users gave Mirion Technologies an outperform vote while only 61.70% of users gave Revvity an outperform vote.

CompanyUnderperformOutperform
Mirion TechnologiesOutperform Votes
16
84.21%
Underperform Votes
3
15.79%
RevvityOutperform Votes
29
61.70%
Underperform Votes
18
38.30%

In the previous week, Revvity had 8 more articles in the media than Mirion Technologies. MarketBeat recorded 19 mentions for Revvity and 11 mentions for Mirion Technologies. Revvity's average media sentiment score of 1.29 beat Mirion Technologies' score of 1.06 indicating that Revvity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mirion Technologies
6 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Revvity
14 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Revvity beats Mirion Technologies on 14 of the 19 factors compared between the two stocks.

Remove Ads
Get Mirion Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for MIR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MIR vs. The Competition

MetricMirion TechnologiesMeasuring & controlling devices IndustryBusiness SectorNYSE Exchange
Market Cap$3.17B$16.35B$6.97B$18.84B
Dividend YieldN/A3.23%2.53%3.78%
P/E Ratio-71.8114.9029.3331.43
Price / Sales3.689.05156.6925.45
Price / Cash17.4817.3831.4017.54
Price / Book1.992.434.584.36
Net Income-$36.10M$538.63M$193.26M$1.02B
7 Day Performance-8.82%-8.68%-4.34%-5.42%
1 Month Performance-8.98%-2.53%-4.23%-5.81%
1 Year Performance24.83%-15.54%0.61%-0.44%

Mirion Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MIR
Mirion Technologies
2.4289 of 5 stars
$13.64
-9.2%
$19.25
+41.1%
+24.8%$3.17B$860.80M-71.812,870News Coverage
Positive News
Gap Down
RVTY
Revvity
3.3854 of 5 stars
$108.60
+1.2%
$136.25
+25.5%
-1.6%$13.05B$2.76B49.1411,500Positive News
Gap Down
AVTR
Avantor
4.7427 of 5 stars
$16.53
-0.1%
$25.50
+54.3%
-38.0%$11.25B$6.78B15.8914,500Positive News
BIO.B
Bio-Rad Laboratories
N/A$265.82
flat
N/A-27.2%$7.45B$2.57B-4.098,200
NVMI
Nova
2.5284 of 5 stars
$203.74
+3.5%
$250.83
+23.1%
-3.8%$5.97B$672.40M35.493,606News Coverage
Positive News
Gap Down
VNT
Vontier
3.933 of 5 stars
$34.51
+2.4%
$44.67
+29.4%
-30.7%$5.13B$2.98B12.558,100Positive News
Gap Down
ST
Sensata Technologies
4.3422 of 5 stars
$27.79
+2.3%
$39.08
+40.7%
-44.9%$4.16B$3.93B33.0820,800Analyst Downgrade
News Coverage
Positive News
CAMT
Camtek
4.5218 of 5 stars
$68.51
+3.7%
$114.11
+66.6%
-35.7%$3.12B$429.23M28.31400Gap Down
TXG
10x Genomics
4.6006 of 5 stars
$10.39
flat
$20.21
+94.6%
-78.1%$1.27B$610.79M-6.841,240Gap Down
TRNS
Transcat
2.8473 of 5 stars
$71.84
+4.0%
$111.50
+55.2%
-32.4%$668.76M$272.20M38.83920Positive News
Gap Down
CTKB
Cytek Biosciences
1.277 of 5 stars
$4.22
+0.5%
$6.42
+52.1%
-43.3%$540.57M$200.45M-52.74500Gap Down
Remove Ads

Related Companies and Tools


This page (NYSE:MIR) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners